| |
| |
|
| Insider
Information: |
Schleifer Leonard S |
| Relationship: |
Bd. Co-Chair, Presiden... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
374,429 |
|
|
Indirect Shares
|
320,901 |
|
|
| Direct
Value |
$358,942,617 |
|
|
|
Indirect Value
|
$307,628,535 |
|
|
| Total
Shares |
695,330 |
|
|
| Total
Value |
$666,571,151 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regeneron Pharmaceuticals Inc |
REGN |
Bd. Co-Chair, Presiden... |
2023-12-11 |
374,429 |
2023-12-11 |
320,901 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
Bd. Co-Chair, President & CEO |
• • – |
2023-12-11 |
4 |
D |
$844.09 |
$10,838,960 |
D/D |
(12,841) |
374,429 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Bd. Co-Chair, President & CEO |
• • – |
2023-12-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,155 |
387,270 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2023-05-15 |
4 |
GA |
$0.00 |
$0 |
I/I |
53,807 |
64,985 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2023-05-15 |
4 |
GD |
$0.00 |
$0 |
I/I |
53,807 |
0 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2022-04-06 |
4 |
AS |
$710.04 |
$1,883,736 |
I/I |
(2,653) |
11,178 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2022-04-05 |
4 |
AS |
$710.05 |
$3,167,533 |
I/I |
(4,461) |
13,831 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2022-03-31 |
4 |
AS |
$710.01 |
$2,049,089 |
I/I |
(2,886) |
18,292 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2021-11-19 |
4 |
D |
$651.96 |
$234,142,959 |
D/D |
(359,137) |
465,922 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2021-11-19 |
4 |
OE |
$179.13 |
$115,030,120 |
D/D |
520,313 |
651,568 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2021-08-19 |
4 |
AS |
$660.03 |
$6,600,300 |
I/I |
(10,000) |
21,178 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2021-08-18 |
4 |
AS |
$650.03 |
$130,006,000 |
D/D |
(200,000) |
304,746 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2021-08-16 |
4 |
AS |
$615.54 |
$6,243,614 |
I/I |
(10,000) |
31,178 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2021-08-06 |
4 |
OE |
$52.03 |
$20,812,000 |
D/D |
400,000 |
596,176 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2021-08-06 |
4 |
D |
$607.51 |
$138,861,598 |
D/D |
(228,575) |
504,746 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2021-05-19 |
4 |
GA |
$0.00 |
$0 |
I/I |
41,178 |
41,178 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2021-05-19 |
4 |
GD |
$0.00 |
$0 |
I/I |
41,178 |
0 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2020-05-12 |
4 |
AS |
$557.51 |
$85,908,042 |
D/D |
(150,922) |
474,499 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2020-05-11 |
4 |
D |
$571.43 |
$92,330,517 |
D/D |
(161,578) |
625,421 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2020-05-11 |
4 |
OE |
$30.63 |
$9,571,875 |
D/D |
312,500 |
722,368 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2019-12-12 |
4 |
D |
$377.16 |
$61,085,965 |
D/D |
(161,963) |
474,499 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2019-12-12 |
4 |
OE |
$21.25 |
$6,638,500 |
D/D |
312,400 |
571,708 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2019-03-21 |
4 |
OE |
$21.25 |
$2,125 |
D/D |
100 |
424,062 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2018-12-13 |
4 |
D |
$377.31 |
$60,419,028 |
D/D |
(160,131) |
423,962 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2018-12-13 |
4 |
OE |
$16.80 |
$5,250,000 |
D/D |
312,500 |
488,014 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2017-12-13 |
4 |
D |
$385.08 |
$52,300,025 |
D/D |
(135,816) |
271,593 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
